1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow VLCAD deficiency: new trials by email Literature Review of VLCAD deficiency trials Research Report on VLCAD deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD Triheptanoin, MCT Oil - Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) | Phase 3 | Active not recruiting | Ultragenyx Pharmaceutical Inc | 69 | 2023-02-28 | 2026-09-17 |
triheptanoin (1)
Ultragenyx Pharmaceutical Inc (1)
Czechia (1) · Germany (1) · Japan (1) · Poland (1) · Saudi Arabia (1) · Spain (1) · Turkey (Türkiye) (1)
2023 (1)